Novel HTS Platforms for TBDA and Nicotinamide Mechanistic Studies
Principal Investigator: Brian VanderVen
Department of Microbiology and Immunology
Email:
bcv8@cornell.edu
Sponsor:
Gates Foundation
Grant Number:
INV-100505
Title:
Novel HTS Platforms for TBDA and Nicotinamide Mechanistic Studies
Project Amount:
$551,142
Project Period:
October 2026
to
September 2028
DESCRIPTION (provided by applicant):
The goal of this project is to discover novel TB targets, screening assays, and to deliver compounds that contribute to the development of safer, simpler and shorter universal TB treatment regimen.